Literature DB >> 28832355

Prehospital hemostatic resuscitation to achieve zero preventable deaths after traumatic injury.

Philip C Spinella1, Andrew P Cap.   

Abstract

PURPOSE OF REVIEW: To describe how hemostatic resuscitation can be used in the prehospital phase of resuscitation to reduce preventable deaths after traumatic injury. RECENT
FINDINGS: Hemorrhagic shock is the leading cause of death that is preventable after injury. The National Academy of Sciences, recently, recommended that achievement of zero preventable deaths after traumatic injury should be the goal of a national trauma system. In the United States, there are an estimated 25 000 preventable deaths per year in the prehospital phase of resuscitation because of traumatic hemorrhagic shock. Therefore, to achieve the goal of zero preventable deaths after injury, both shock and hemostatic dysfunction need to be addressed rapidly in the prehospital phase of resuscitation. This review will highlight the epidemiology and outcomes of traumatic hemorrhagic shock, and explore potential solutions such as group O whole blood and platelets stored at 2-6°C. Trauma research receives the lowest funding relative to the burden of morbidity and mortality it creates when compared with all other diseases. Increased resources are required to achieve zero preventable deaths after injury.
SUMMARY: Prehospital hemostatic resuscitation has the potential to significantly reduce preventable death from hemorrhage.

Entities:  

Mesh:

Year:  2017        PMID: 28832355     DOI: 10.1097/MOH.0000000000000386

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  9 in total

1.  Intravenous administration of synthetic platelets (SynthoPlate) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis.

Authors:  Mitchell R Dyer; DaShawn Hickman; Norman Luc; Shannon Haldeman; Patricia Loughran; Christa Pawlowski; Anirban Sen Gupta; Matthew D Neal
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

2.  Effects of platelet-sparing leukocyte reduction and agitation methods on in vitro measures of hemostatic function in cold-stored whole blood.

Authors:  Kenneth E Remy; Mark H Yazer; Arun Saini; Ajlana Mehanovic-Varmaz; Sharon R Rogers; Andrew P Cap; Philip C Spinella
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

Review 3.  The effect of platelet storage temperature on haemostatic, immune, and endothelial function: potential for personalised medicine.

Authors:  Susan M Shea; Kimberly A Thomas; Philip C Spinella
Journal:  Blood Transfus       Date:  2019-07       Impact factor: 3.443

4.  Metabolic phenotypes of standard and cold-stored platelets.

Authors:  Angelo D'Alessandro; Kimberly A Thomas; Davide Stefanoni; Fabia Gamboni; Susan M Shea; Julie A Reisz; Philip C Spinella
Journal:  Transfusion       Date:  2019-12-27       Impact factor: 3.157

5.  Recommendations on RBC Transfusion in Critically Ill Children With Nonlife-Threatening Bleeding or Hemorrhagic Shock From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Oliver Karam; Robert T Russell; Paul Stricker; Adam M Vogel; Scot T Bateman; Stacey L Valentine; Philip C Spinella
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

Review 6.  Blood Group Testing.

Authors:  Hong-Yang Li; Kai Guo
Journal:  Front Med (Lausanne)       Date:  2022-02-11

Review 7.  The Role of Whole Blood Transfusions in Civilian Trauma: A Review of Literature in Military and Civilian Trauma.

Authors:  Shane Kronstedt; Joon Lee; David Millner; Connor Mattivi; Halli LaFrankie; Lorenzo Paladino; Jeffrey Siegler
Journal:  Cureus       Date:  2022-04-18

Review 8.  Why are bleeding trauma patients still dying? Towards a systems hypothesis of trauma.

Authors:  Geoffrey P Dobson; Jodie L Morris; Hayley L Letson
Journal:  Front Physiol       Date:  2022-09-06       Impact factor: 4.755

9.  The Immunologic Effect of Early Intravenous Two and Four Gram Bolus Dosing of Tranexamic Acid Compared to Placebo in Patients With Severe Traumatic Bleeding (TAMPITI): A Randomized, Double-Blind, Placebo-Controlled, Single-Center Trial.

Authors:  Philip C Spinella; Kimberly A Thomas; Isaiah R Turnbull; Anja Fuchs; Kelly Bochicchio; Douglas Schuerer; Stacey Reese; Adrian A Coleoglou Centeno; Christopher B Horn; Jack Baty; Susan M Shea; M Adam Meledeo; Anthony E Pusateri; Jerrold H Levy; Andrew P Cap; Grant V Bochicchio
Journal:  Front Immunol       Date:  2020-09-08       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.